International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1600-6143|15|4|1091-1100

ISSN: 1600-6135

Source: AMERICAN JOURNAL OF TRANSPLANTATION, Vol.15, Iss.4, 2015-04, pp. : 1091-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract